AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,494,727 | -27.0% | 60,393 | -16.5% | 0.00% | 0.0% |
| Q2 2023 | $2,047,479 | +3.8% | 72,298 | -15.8% | 0.00% | 0.0% |
| Q1 2023 | $1,971,630 | -23.8% | 85,835 | -6.8% | 0.00% | 0.0% |
| Q4 2022 | $2,585,747 | +523.1% | 92,085 | +528.1% | 0.00% | – |
| Q3 2022 | $415,000 | -76.4% | 14,660 | -81.5% | 0.00% | -100.0% |
| Q2 2022 | $1,755,000 | +31.4% | 79,135 | +72.5% | 0.00% | – |
| Q1 2022 | $1,336,000 | -78.1% | 45,863 | -75.3% | 0.00% | -100.0% |
| Q4 2021 | $6,095,000 | +40.6% | 185,425 | +97.4% | 0.00% | +100.0% |
| Q3 2021 | $4,335,000 | +531.0% | 93,921 | +653.4% | 0.00% | – |
| Q2 2021 | $687,000 | -49.5% | 12,466 | -52.7% | 0.00% | – |
| Q1 2021 | $1,360,000 | +129.0% | 26,337 | +92.2% | 0.00% | – |
| Q4 2020 | $594,000 | +33.5% | 13,705 | +7.8% | 0.00% | – |
| Q3 2020 | $445,000 | +196.7% | 12,710 | +352.8% | 0.00% | – |
| Q2 2020 | $150,000 | -93.3% | 2,807 | -95.5% | 0.00% | -100.0% |
| Q1 2020 | $2,230,000 | -10.4% | 62,842 | +20.6% | 0.00% | 0.0% |
| Q4 2019 | $2,490,000 | +36.1% | 52,129 | -7.6% | 0.00% | 0.0% |
| Q3 2019 | $1,829,000 | +553.2% | 56,438 | +904.4% | 0.00% | – |
| Q2 2019 | $280,000 | -9.7% | 5,619 | +22.2% | 0.00% | – |
| Q1 2019 | $310,000 | -89.0% | 4,599 | -92.5% | 0.00% | -100.0% |
| Q4 2018 | $2,825,000 | +47.2% | 61,270 | +146.2% | 0.00% | 0.0% |
| Q3 2018 | $1,919,000 | +196.6% | 24,883 | +224.0% | 0.00% | – |
| Q2 2018 | $647,000 | -91.0% | 7,679 | -91.2% | 0.00% | -100.0% |
| Q1 2018 | $7,167,000 | +329.9% | 87,642 | +200.6% | 0.00% | +200.0% |
| Q4 2017 | $1,667,000 | -49.3% | 29,156 | -40.8% | 0.00% | -50.0% |
| Q3 2017 | $3,288,000 | +66.3% | 49,257 | +28.2% | 0.00% | +100.0% |
| Q2 2017 | $1,977,000 | +4.1% | 38,427 | +18.2% | 0.00% | 0.0% |
| Q1 2017 | $1,899,000 | -23.8% | 32,515 | -45.5% | 0.00% | 0.0% |
| Q4 2016 | $2,491,000 | +33.9% | 59,678 | +69.4% | 0.00% | 0.0% |
| Q3 2016 | $1,861,000 | +12.7% | 35,223 | -10.7% | 0.00% | 0.0% |
| Q2 2016 | $1,652,000 | -42.1% | 39,450 | -43.9% | 0.00% | -50.0% |
| Q1 2016 | $2,853,000 | -44.4% | 70,285 | -11.1% | 0.00% | -33.3% |
| Q4 2015 | $5,131,000 | +1195.7% | 79,040 | +1309.4% | 0.00% | – |
| Q3 2015 | $396,000 | -37.7% | 5,608 | -2.1% | 0.00% | – |
| Q2 2015 | $636,000 | +0.6% | 5,726 | -14.5% | 0.00% | – |
| Q1 2015 | $632,000 | -96.2% | 6,699 | -95.5% | 0.00% | -100.0% |
| Q4 2014 | $16,847,000 | – | 150,364 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |